File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Evidence of dysexecutive syndrome in patients with acromegaly

TitleEvidence of dysexecutive syndrome in patients with acromegaly
Authors
KeywordsAcromegaly
Disease duration
Dysexecutive function
IGF-1
Issue Date2017
Citation
Pituitary, 2017, v. 20, n. 6, p. 661-667 How to Cite?
AbstractPurpose: This study aimed to explore different aspects of executive function in patients with acromegaly and investigate the cause of dysexecutive syndrome in these patients. Methods: We conducted five typical executive function tests (Stroop test, verbal fluency [VF] test, Hayling Sentence Completion Test [HSCT], N-back test, and Sustained Attention to Response Task [SART]) on 42 acromegalic patients and 42 strictly matched healthy controls. Comparative analyses were conducted for five major executive function domains. The Dysexecutive Questionnaire (DEX) was used to assess patients’ subjective feelings about their executive function. All patients underwent a magnetic resonance imaging (MRI) examination and a blood test to determine their pituitary hormone levels before the tests were performed. Results: The patients exhibited worse results on the Stroop test, VF test, HSCT and N-back test compared to the healthy control group. Moreover, part B of the HSCT and the N-back test performance were negatively correlated with IGF-1 concentrations, and the duration of the disease was significantly associated with the Stroop color task results. Conclusions: Acromegalic patients were severely impaired in semantic inhibition, executive processing, working memory and executive inhibition, and they have realized a portion of these deficits. A high level of IGF-1, disease duration may contribute to the impairment of specific aspects of executive function.
Persistent Identifierhttp://hdl.handle.net/10722/367683
ISSN
2023 Impact Factor: 3.3
2023 SCImago Journal Rankings: 1.091

 

DC FieldValueLanguage
dc.contributor.authorShan, Shaobo-
dc.contributor.authorFang, Lingling-
dc.contributor.authorHuang, Jia-
dc.contributor.authorChan, Raymond C.K.-
dc.contributor.authorJia, Guijun-
dc.contributor.authorWan, Weiqing-
dc.date.accessioned2025-12-19T07:58:40Z-
dc.date.available2025-12-19T07:58:40Z-
dc.date.issued2017-
dc.identifier.citationPituitary, 2017, v. 20, n. 6, p. 661-667-
dc.identifier.issn1386-341X-
dc.identifier.urihttp://hdl.handle.net/10722/367683-
dc.description.abstractPurpose: This study aimed to explore different aspects of executive function in patients with acromegaly and investigate the cause of dysexecutive syndrome in these patients. Methods: We conducted five typical executive function tests (Stroop test, verbal fluency [VF] test, Hayling Sentence Completion Test [HSCT], N-back test, and Sustained Attention to Response Task [SART]) on 42 acromegalic patients and 42 strictly matched healthy controls. Comparative analyses were conducted for five major executive function domains. The Dysexecutive Questionnaire (DEX) was used to assess patients’ subjective feelings about their executive function. All patients underwent a magnetic resonance imaging (MRI) examination and a blood test to determine their pituitary hormone levels before the tests were performed. Results: The patients exhibited worse results on the Stroop test, VF test, HSCT and N-back test compared to the healthy control group. Moreover, part B of the HSCT and the N-back test performance were negatively correlated with IGF-1 concentrations, and the duration of the disease was significantly associated with the Stroop color task results. Conclusions: Acromegalic patients were severely impaired in semantic inhibition, executive processing, working memory and executive inhibition, and they have realized a portion of these deficits. A high level of IGF-1, disease duration may contribute to the impairment of specific aspects of executive function.-
dc.languageeng-
dc.relation.ispartofPituitary-
dc.subjectAcromegaly-
dc.subjectDisease duration-
dc.subjectDysexecutive function-
dc.subjectIGF-1-
dc.titleEvidence of dysexecutive syndrome in patients with acromegaly-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s11102-017-0831-9-
dc.identifier.pmid28823099-
dc.identifier.scopuseid_2-s2.0-85027689451-
dc.identifier.volume20-
dc.identifier.issue6-
dc.identifier.spage661-
dc.identifier.epage667-
dc.identifier.eissn1573-7403-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats